Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Total Liabilities (2023 - 2025)

Metagenomi (MGX) has disclosed Total Liabilities for 3 consecutive years, with $62.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 30.35% to $62.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.5 million through Dec 2025, down 30.35% year-over-year, with the annual reading at $62.5 million for FY2025, 30.35% down from the prior year.
  • Total Liabilities for Q4 2025 was $62.5 million at Metagenomi, down from $69.5 million in the prior quarter.
  • The five-year high for Total Liabilities was $149.7 million in Q4 2023, with the low at $119021.0 in Q3 2023.
  • Average Total Liabilities over 3 years is $90.4 million, with a median of $89.9 million recorded in 2023.
  • Peak annual rise in Total Liabilities hit 86082.27% in 2024, while the deepest fall reached 40.04% in 2024.
  • Over 3 years, Total Liabilities stood at $149.7 million in 2023, then crashed by 40.04% to $89.7 million in 2024, then crashed by 30.35% to $62.5 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $62.5 million, $69.5 million, and $76.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.